Skip to main navigation
News
Careers
Contact Us
Get Email Alerts
ADMA BioCenters
About us
Our Company
About ADMA Biologics
What We Do
Advocacy
Business Ethics & Compliance
Our People
Senior Leadership Team
Board of Directors
Scientific Advisory Board
Science & Technology
Plasma & IVIG
Our Patented Immunotechnology
About Plasma & IVIG
Medical Affairs
Medical Affairs Overview
Publications
Primary Immunodeficiency Disease
About Primary Immunodeficiency Disease (PI)
Our Products
Our Products
Asceniv
Bivigam®
Nabi-HB®
Manufacturing
Manufacturing Process
Contract Manufacturing
Investors
Overview
Press Releases
Press Releases
Email Alerts
Company Info
Company Information
Corporate Presentation
Management Team
Contacts
FAQs
Analyst Coverage
Analyst Coverage
Events & Webcasts
Events & Webcasts
Financial Info
Financial Information
Financial Results
Balance Sheet
Income Statement
Cash Flow
Annual Reports
Stock Info
Stock Data & Quote
Historical Data
SEC Filings
SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Documents
News
Careers
Contact Us
Get Email Alerts
ADMA BioCenters
About Us
Our Company
About ADMA Biologics
Advocacy
What We Do
Business Ethics & Compliance
Our People
Senior Leadership Team
Board of Directors
Scientific Advisory Board
Science & Technology
Plasma & IVIG
Our Patented Immunotechnology
About Plasma & IVIG
Primary Immunodeficiency Disease
About Primary Immunodeficiency Disease (PI)
Medical Affairs
Medical Affairs Overview
Publications
Our Products
OUR PRODUCTS
Overview
PRODUCT WEBSITES
Asceniv™
Bivigam®
Nabi-HB®
Manufacturing
PROCESS & CAPABILITIES
Manufacturing Process
Contract Manufacturing Capabilities
Investors
Press Releases
Press Releases
Email Alerts
Financial Info
Financial Information
Financial Results
Balance Sheet
Income Statement
Cash Flow
Annual Reports
Company Info
Company Information
Corporate Presentation
Management Team
Contacts
FAQs
Stock Info
Stock Data & Quote
Historical Data
Analyst Coverage
Analyst Coverage
SEC Filings
SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Events & Webcasts
Events & Webcasts
Governance
Board of Directors
Board Committees
Documents
Our Company
About ADMA Biologics
Advocacy
What We Do
Business Ethics & Compliance
Our People
Senior Leadership Team
Board of Directors
Scientific Advisory Board
Plasma & IVIG
Our Patented Immunotechnology
About Plasma & IVIG
Primary Immunodeficiency Disease
About Primary Immunodeficiency Disease (PI)
Medical Affairs
Medical Affairs Overview
Publications
OUR PRODUCTS
Overview
PRODUCT WEBSITES
Asceniv™
Bivigam®
Nabi-HB®
PROCESS & CAPABILITIES
Manufacturing Process
Contract Manufacturing Capabilities
Press Releases
Press Releases
Email Alerts
Financial Info
Financial Information
Financial Results
Balance Sheet
Income Statement
Cash Flow
Annual Reports
Company Info
Company Information
Corporate Presentation
Management Team
Contacts
FAQs
Stock Info
Stock Data & Quote
Historical Data
Analyst Coverage
Analyst Coverage
SEC Filings
SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Events & Webcasts
Events & Webcasts
Governance
Board of Directors
Board Committees
Documents
Event Details
ADMA Biologics 1Q 2024 Earnings Call
May 9, 2024
4:30 PM EDT
Webcast
